| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.02. | imec iStart launches €75m Future Fund | 2 | eeNews Europe | ||
| 03.01. | Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator | 1 | Benzinga.com | ||
| 02.01. | Windtree Therapeutics Announces Reduction In Arrythmias In A New Study With Istaroxime And A Pure SERCA2a Activator | 259 | GlobeNewswire (Europe) | The new preclinical data further supports istaroxime clinical data from three Phase 2 studies Arrythmias can be a serious complication of current rescue therapies for treatment of patients with acute... ► Artikel lesen | |
| 22.12.23 | iSTAR Medical continues European expansion with first MINIject® surgeries in the Netherlands | 313 | GlobeNewswire (Europe) | For immediate release
iSTAR Medical continues European expansion with first MINIject® surgeries in the Netherlands
WAVRE, Belgium - 22 December 2023: iSTAR Medical, a medtech company delivering... ► Artikel lesen | |
| 19.12.23 | Windtree: Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024 | 289 | ACCESSWIRE | WARRINGTON, PA / ACCESSWIRE / December 19, 2023 / Windtree Therapeutics, Inc. (NASDAQ:WINT) has recently enrolled the first subject in its phase 2 SEISMiC Extension Study to evaluate istaroxime in the... ► Artikel lesen | |
| 18.12.23 | Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024 | 1 | Benzinga.com | ||
| 18.12.23 | Windtree Therapeutics Announces the Start of Patient Dosing In Phase 2 SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock | 213 | GlobeNewswire (Europe) | SEISMiC Extension Study results are anticipated in mid-2024 and expected to provide dose optimization for Phase 3 The Company is also progressing a parallel SCAI Stage C Phase 2 study with istaroxime... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 261 |
| BAYER | 216 |
| NEL | 202 |
| NVIDIA | 178 |
| TUI | 176 |
| SIEMENS ENERGY | 164 |
| RHEINMETALL | 158 |
| MERCEDES-BENZ | 145 |
| PLUG POWER | 144 |
| BYD | 132 |
| NOVAVAX | 127 |
| DEUTSCHE BANK | 115 |
| PALANTIR TECHNOLOGIES | 111 |
| TESLA | 110 |
| RWE | 106 |
| ALLIANZ | 96 |
| BASF | 92 |
| VOLKSWAGEN | 90 |
| DEUTSCHE LUFTHANSA | 89 |
| COMMERZBANK | 79 |
| THYSSENKRUPP | 74 |
| AMAZON | 71 |
| INFINEON | 64 |
| NORDEX | 64 |
| SUPER MICRO COMPUTER | 64 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
